AdaptHealth Posts $745.6M in Third-Quarter Revenue
AHCO is trading near its 52-week low of $5.21 (13% above the low).
Summary
AdaptHealth reported third-quarter revenue of $745.6M, alongside a third-quarter net loss of $154M, or $1.13 loss per share. The top-line figure lands after a rough second quarter, when the company posted a $133.9M net loss driven by a $144.2M goodwill impairment, cut full-year 2026 guidance, and launched a restructuring. It also follows the September 9 CFO transition to Harriss Currie, and the company has now revised its 2026 guidance. Revenue alone doesn't settle the story here — the impairment and guidance cut mean margins, cash flow and any update to the 2026 outlook carry more weight than the sales line.
At the time of this announcement, AHCO was trading at $5.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $805.8M. The 52-week trading range was $5.21 to $13.43. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.